Identification of lipid metabolism-related genes in dapagliflozin treated rats with diabetic cardiomyopathy by bioinformatics
Xun Huang,
No information about this author
Yunhong Wang,
No information about this author
Rong Wan
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 20, 2025
Background
Diabetic
cardiomyopathy
(DCM)
is
a
heart
disease
caused
by
the
metabolic
disorders
of
glucose
and
lipids
associated
with
diabetes,
leading
to
failure
death
in
diabetic
patients.
Dapagliflozin
(DAPA)
serves
as
treatment
for
managing
blood
levels
individuals
type
2
diabetes
mellitus
(DM).
However,
specific
mechanisms
which
DAPA
treats
DCM
are
not
yet
fully
understood.
Methods
Sprague-Dawley
(SD)
rats
(n
=
5/group)
were
randomly
divided
into
control,
model,
intervention
groups.
Lipid
metabolism-related
genes
(LMRGs)
gotten
from
publicly
available
database.
Differential
expression
analysis
model
vs.
control
samples
was
performed
obtain
differentially
expressed
(DEGs),
result
recorded
DEGs-Model
DEGs-Intervention.
The
intersection
opposing
trends
between
DEGs-Intervention
considered
candidate
genes.
Subsequently,
LMRGs
intersected
acquire
hub
genes,
analyzed
each
group
samples.
Then,
mechanism
action
these
investigated
through
functional
enrichment
analysis,
gene
set
(GSEA),
predictive
m6A
binding
sites.
Results
Ultimately,
68
590
derive
(Acsbg1
Etnppl).
Acsbg1
significantly
increase
compared
group.
RT-qPCR
results
confirmed
obviously
higher
group,
while
Etnppl
lower
compare
groups
While
Functional
analyses
indicated
that
fatty
acid
metabolism.
findings
GSEA
might
affect
occurrence
progression
lysosome.
And
located
at
UCAGG
RNA
secondary
structure.
Conclusion
This
study
identified
Etnppl)
potential
new
focal
points
diagnosing
treating
DCM.
Language: Английский
Yunvjian decoction mitigates hyperglycemia in rats induced by a high-fat diet and streptozotocin via reducing oxidative stress in pancreatic beta cells
Jie Lv,
No information about this author
Meng Su,
No information about this author
Yansong Wang
No information about this author
et al.
Journal of Ethnopharmacology,
Journal Year:
2024,
Volume and Issue:
327, P. 118045 - 118045
Published: March 11, 2024
Language: Английский
Nutritional Provision of Iron Complexes by the Major Allergen Alt a 1 to Human Immune Cells Decreases Its Presentation
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(15), P. 11934 - 11934
Published: July 25, 2023
Alternaria
alternata
is
a
common
fungus
strongly
related
with
severe
allergic
asthma,
80%
of
affected
individuals
being
sensitized
solely
to
its
major
allergen
Alt
1.
Here,
we
assessed
the
function
1
as
an
innate
defense
protein
binding
micronutrients,
such
iron–quercetin
complexes
(FeQ2),
and
impact
on
antigen
presentation
in
vitro.
Binding
FeQ2
was
determined
docking
calculations.
Recombinant
generated,
ability,
well
secondary
quaternary
structure,
by
UV-VIS,
CD,
DLS
spectroscopy.
Proteolytic
functions
were
casein
gelatine
zymography.
Uptake
empty
apo–
or
ligand-filled
holoAlt
human
monocytic
THP1
cells
under
presence
dynamin
clathrin-inhibitors,
activation
Arylhydrocarbon
receptor
(AhR)
using
reporter
cellline
AZ-AHR.
Human
PBMCs
stimulated
for
phenotypic
changes
monocytes
flow
cytometry.
bound
tetramer
calculated
Kd
values
reaching
pico-molar
levels
surpassing
affinities
quercetin
alone
factor
5000
tetramer.
apoAlt
but
not
holoAlta
showed
low
enzymatic
activity
against
hexamer
gelatin
trimer.
holo–Alt
occurred
partly
clathrin-dependent,
decreasing
labile
iron
facilitating
quercetin-dependent
AhR
activation.
In
uptake
significantly
decreased
surface
expression
costimulatory
CD86,
also
HLADR,
thereby
reducing
effective
presentation.
We
show
here
first
time
that
nutritional
complexes,
FeQ2,
alters
dampens
immune
response,
supporting
notion
only
becomes
immunogenic
deprivation.
Language: Английский
A real-world observational study on the effect of Qingre Lishi decoction on glycemic profile using continuous glucose monitoring in obese type 2 diabetes adults
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 23, 2024
To
observe
the
clinical
efficacy
and
safety
of
Qingre
Lishi
decoction
in
treating
newly
diagnosed
overweight
obese
patients
with
type
2
diabetes
mellitus
(T2DM)
from
an
evidence-based
medical
perspective.
Language: Английский